Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy.
COVID-19
SARS-CoV-2
migrants
prevalence
social housing
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
11 10 2021
11 10 2021
Historique:
received:
10
08
2021
revised:
28
09
2021
accepted:
08
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
29
10
2021
Statut:
epublish
Résumé
The northern Italian region of Lombardy has been severely affected by the COVID-19 pandemic since its arrival in Europe. However, there are only a few published studies of the possible influence of social and cultural factors on its prevalence in the general population. This cross-sectional study of the San Siro social-housing neighbourhood of Milan, which was carried about between 23 December 2020 and 19 February 2021, found that the prevalence of anti-SARS-CoV-2 nucleocapsid antibodies in the population as a whole was 12.4% (253/2044 inhabitants), but there was a more than two-fold difference between non-Italians and Italians (23.3% vs. 9.1%). Multivariable analyses showed that being more than 50 years old, living in crowded accommodation, being a non-Italian, and having a low educational level were associated with higher odds of a positive SARS-CoV-2 test, whereas a higher level of education, retirement, and being a former or current cigarette smoker were inversely associated with SARS-CoV-2 infection. Our findings are in line with previous observations indicating that a lower socio-economic status may be a risk factor for COVID-19 and show that non-Italians are disproportionately affected by SARS-CoV-2 infection. This suggests that public health policies should focus more on disadvantaged populations.
Identifiants
pubmed: 34682369
pii: ijerph182010621
doi: 10.3390/ijerph182010621
pmc: PMC8535198
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CISOM, ARMANI OLIMPIA MILANO, ASST FBF-SACCO, UNIMI, POLIMI, TECHNOGENETICS
ID : Na
Références
Addiction. 2021 Jun;116(6):1319-1368
pubmed: 33007104
JAMA Intern Med. 2021 Feb 1;181(2):229-236
pubmed: 33165560
Am J Prev Med. 2020 Sep;59(3):326-332
pubmed: 32703702
BMC Infect Dis. 2012 Apr 20;12:95
pubmed: 22520624
Blood Transfus. 2021 May;19(3):181-189
pubmed: 33539289
Euro Surveill. 2020 Jun;25(24):
pubmed: 32583766
BMC Med. 2020 Jul 1;18(1):206
pubmed: 32605617
JAMA. 2020 Jun 2;323(21):2192-2195
pubmed: 32347898
Eur J Intern Med. 2021 Apr;86:41-47
pubmed: 33579579
Public Health. 2020 Jun;183:110-111
pubmed: 32502699
Scand J Public Health. 2021 Feb;49(1):48-56
pubmed: 33406993
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
Lancet Glob Health. 2021 Feb;9(2):e110-e111
pubmed: 33197394
J Infect. 2020 Dec;81(6):e10-e12
pubmed: 32961253
Eur J Public Health. 2020 Aug 1;30(4):617-618
pubmed: 32638998
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Lancet Healthy Longev. 2020 Nov;1(2):e80-e88
pubmed: 33521770
Int J Epidemiol. 2021 Jul 9;50(3):732-742
pubmed: 33657223
PLoS One. 2021 Feb 24;16(2):e0246513
pubmed: 33626045
BMC Public Health. 2004 Jun 03;4:19
pubmed: 15176983